ARGA Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ARGA Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$978K	Hold	5,172	–	–	0.03%	75
2025 Q4	$879K	Hold	5,172	–	–	0.02%	78
2025 Q3	$682K	Sell	5,172 -4,856	-48%	-$582K	0.02%	85
2025 Q2	$1.06M	Hold	10,028	–	–	0.03%	80
2025 Q1	$1.24M	Sell	10,028 -2,167	-18%	-$283K	0.04%	70
2024 Q4	$1.5M	Hold	12,195	–	–	0.05%	59
2024 Q3	$1.36M	Buy	12,195 +5,562	+84%	+$610K	0.05%	74
2024 Q2	$708K	Buy	6,633 +3,089	+87%	+$340K	0.02%	96
2024 Q1	$427K	Hold	3,544	–	–	0.01%	123
2023 Q4	$436K	Buy	+3,544	New	+$442K	0.02%	127

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

ARGA Investment Management's JAZZ Position: Q1 2026 in Review

ARGA Investment Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 5,172 shares worth $978K. The position accounts for 0.03% of the portfolio, ranked #75.

ARGA Investment Management first reported a position in JAZZ in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.5M in Q4 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

ARGA Investment Management held 5,172 shares of Jazz Pharmaceuticals worth $978K as of Q1 2026.
ARGA Investment Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.03% of ARGA Investment Management's portfolio in Q1 2026, its #75 holding.
ARGA Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
ARGA Investment Management's Jazz Pharmaceuticals position peaked at $1.5M in Q4 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on ARGA Investment Management's 13F filing for Q1 2026, filed 30 Apr 2026.